title: Infectious complications of penile prosthesis surgery.
abstract: Penile prosthetic surgery has become an increasingly common procedure. However, infection of the prosthesis remains a significant complication that almost always results in loss of the device. We present our 10-year experience with 9 infected prostheses among 417 total penile implants, for an over-all incidence of infectious complications of 2.2 per cent. A strict, broad-spectrum antibiotic schedule was adhered to rigidly by all patients, beginning preoperatively and continuing for a total of 10 days of perioperative coverage. Staphylococcus species were cultured in 56 per cent of the infected patients and in 100 per cent of the patients with positive cultures. Spinal cord injury patients showed a particular predisposition to prosthetic infection, with a 15 per cent incidence of infectious complications. Two other patients became infected after dental procedures and the need for routine antibiotic prophylaxis in the penile prosthesis patient is emphasized. Urinary tract instrumentation at the time of prosthetic implantation, whether planned or incidental, also appears to add a potentially avoidable risk for subsequent infection.
authors: Division of Urology, Stanford University Medical Center, California.
authors: J N
authors: JN
authors: Kabalin
authors: R
authors: R
authors: Kessler
mesh_terms: D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002437:Cefazolin / Q000627:therapeutic use; D007172:Erectile Dysfunction / Q000628:therapy*; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D010413:Penis; D011292:Premedication; D019736:Prostheses and Implants; D012307:Risk Factors; D013119:Spinal Cord Injuries / Q000150:complications; D013203:Staphylococcal Infections / Q000209:etiology / Q000517:prevention & control; D013530:Surgical Wound Infection / Q000209:etiology* / Q000517:prevention & control; D014031:Tobramycin / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D005839:Gentamicins; D002437:Cefazolin; D014031:Tobramycin